Literature DB >> 21359847

Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay.

Rachel D Burnside1, Romela Pasion, Fady M Mikhail, Andrew J Carroll, Nathaniel H Robin, Erin L Youngs, Inder K Gadi, Elizabeth Keitges, Vikram L Jaswaney, Peter R Papenhausen, Venkateswara R Potluri, Hiba Risheg, Brooke Rush, Janice L Smith, Stuart Schwartz, James H Tepperberg, Merlin G Butler.   

Abstract

The proximal long arm of chromosome 15 has segmental duplications located at breakpoints BP1-BP5 that mediate the generation of NAHR-related microdeletions and microduplications. The classical Prader-Willi/Angelman syndrome deletion is flanked by either of the proximal BP1 or BP2 breakpoints and the distal BP3 breakpoint. The larger Type I deletions are flanked by BP1 and BP3 in both Prader-Willi and Angelman syndrome subjects. Those with this deletion are reported to have a more severe phenotype than individuals with either Type II deletions (BP2-BP3) or uniparental disomy 15. The BP1-BP2 region spans approximately 500 kb and contains four evolutionarily conserved genes that are not imprinted. Reports of mutations or disturbed expression of these genes appear to impact behavioral and neurological function in affected individuals. Recently, reports of deletions and duplications flanked by BP1 and BP2 suggest an association with speech and motor delays, behavioral problems, seizures, and autism. We present a large cohort of subjects with copy number alteration of BP1 to BP2 with common phenotypic features. These include autism, developmental delay, motor and language delays, and behavioral problems, which were present in both cytogenetic groups. Parental studies demonstrated phenotypically normal carriers in several instances, and mildly affected carriers in others, complicating phenotypic association and/or causality. Possible explanations for these results include reduced penetrance, altered gene dosage on a particular genetic background, or a susceptibility region as reported for other areas of the genome implicated in autism and behavior disturbances.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21359847      PMCID: PMC6814187          DOI: 10.1007/s00439-011-0970-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  47 in total

Review 1.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

2.  Functional characterization of NIPA2, a selective Mg2+ transporter.

Authors:  Angela Goytain; Rochelle M Hines; Gary A Quamme
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-30       Impact factor: 4.249

3.  Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study.

Authors:  A Philippe; M Martinez; M Guilloud-Bataille; C Gillberg; M Råstam; E Sponheim; M Coleman; M Zappella; H Aschauer; L Van Maldergem; C Penet; J Feingold; A Brice; M Leboyer; L van Malldergerme
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

4.  Autism spectrum disorder in the second year: stability and change in syndrome expression.

Authors:  Katarzyna Chawarska; Ami Klin; Rhea Paul; Fred Volkmar
Journal:  J Child Psychol Psychiatry       Date:  2007-02       Impact factor: 8.982

Review 5.  Clinical genetic evaluation of the child with mental retardation or developmental delays.

Authors:  John B Moeschler; Michael Shevell
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

6.  A large and complex structural polymorphism at 16p12.1 underlies microdeletion disease risk.

Authors:  Francesca Antonacci; Jeffrey M Kidd; Tomas Marques-Bonet; Brian Teague; Mario Ventura; Santhosh Girirajan; Can Alkan; Catarina D Campbell; Laura Vives; Maika Malig; Jill A Rosenfeld; Blake C Ballif; Lisa G Shaffer; Tina A Graves; Richard K Wilson; David C Schwartz; Evan E Eichler
Journal:  Nat Genet       Date:  2010-08-22       Impact factor: 38.330

7.  NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6).

Authors:  Shirley Rainier; Jing-Hua Chai; Debra Tokarz; Robert D Nicholls; John K Fink
Journal:  Am J Hum Genet       Date:  2003-09-23       Impact factor: 11.025

8.  Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports.

Authors:  B Menten; N Maas; B Thienpont; K Buysse; J Vandesompele; C Melotte; T de Ravel; S Van Vooren; I Balikova; L Backx; S Janssens; A De Paepe; B De Moor; Y Moreau; P Marynen; J-P Fryns; G Mortier; K Devriendt; F Speleman; J R Vermeesch
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

9.  Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.

Authors:  Marianne Doornbos; Birgit Sikkema-Raddatz; Claudia A L Ruijvenkamp; Trijnie Dijkhuizen; Emilia K Bijlsma; Antoinet C J Gijsbers; Yvonne Hilhorst-Hofstee; Roel Hordijk; Krijn T Verbruggen; W S Mieke Kerstjens-Frederikse; Ton van Essen; Klaas Kok; Anneke T van Silfhout; Martijn Breuning; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Med Genet       Date:  2009-03-27       Impact factor: 2.708

10.  Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes.

Authors:  Heather C Mefford; Andrew J Sharp; Carl Baker; Andy Itsara; Zhaoshi Jiang; Karen Buysse; Shuwen Huang; Viv K Maloney; John A Crolla; Diana Baralle; Amanda Collins; Catherine Mercer; Koen Norga; Thomy de Ravel; Koen Devriendt; Ernie M H F Bongers; Nicole de Leeuw; William Reardon; Stefania Gimelli; Frederique Bena; Raoul C Hennekam; Alison Male; Lorraine Gaunt; Jill Clayton-Smith; Ingrid Simonic; Soo Mi Park; Sarju G Mehta; Serena Nik-Zainal; C Geoffrey Woods; Helen V Firth; Georgina Parkin; Marco Fichera; Santina Reitano; Mariangela Lo Giudice; Kelly E Li; Iris Casuga; Adam Broomer; Bernard Conrad; Markus Schwerzmann; Lorenz Räber; Sabina Gallati; Pasquale Striano; Antonietta Coppola; John L Tolmie; Edward S Tobias; Chris Lilley; Lluis Armengol; Yves Spysschaert; Patrick Verloo; Anja De Coene; Linde Goossens; Geert Mortier; Frank Speleman; Ellen van Binsbergen; Marcel R Nelen; Ron Hochstenbach; Martin Poot; Louise Gallagher; Michael Gill; Jon McClellan; Mary-Claire King; Regina Regan; Cindy Skinner; Roger E Stevenson; Stylianos E Antonarakis; Caifu Chen; Xavier Estivill; Björn Menten; Giorgio Gimelli; Susan Gribble; Stuart Schwartz; James S Sutcliffe; Tom Walsh; Samantha J L Knight; Jonathan Sebat; Corrado Romano; Charles E Schwartz; Joris A Veltman; Bert B A de Vries; Joris R Vermeesch; John C K Barber; Lionel Willatt; May Tassabehji; Evan E Eichler
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

View more
  97 in total

1.  An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity.

Authors:  Kyoko Takano; Dan Liu; Patrick Tarpey; Esther Gallant; Alex Lam; Shawn Witham; Emil Alexov; Alka Chaubey; Roger E Stevenson; Charles E Schwartz; Philip G Board; Angela F Dulhunty
Journal:  Hum Mol Genet       Date:  2012-07-19       Impact factor: 6.150

2.  Parental origin impairment of synaptic functions and behaviors in cytoplasmic FMRP interacting protein 1 (Cyfip1) deficient mice.

Authors:  Leeyup Chung; Xiaoming Wang; Li Zhu; Aaron J Towers; Xinyu Cao; Il Hwan Kim; Yong-hui Jiang
Journal:  Brain Res       Date:  2015-10-17       Impact factor: 3.252

3.  Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.

Authors:  A Oguro-Ando; C Rosensweig; E Herman; Y Nishimura; D Werling; B R Bill; J M Berg; F Gao; G Coppola; B S Abrahams; D H Geschwind
Journal:  Mol Psychiatry       Date:  2014-10-14       Impact factor: 15.992

4.  Copy number variation analysis in 83 children with early-onset developmental and epileptic encephalopathy after targeted resequencing of a 109-epilepsy gene panel.

Authors:  Kyoko Hirabayashi; Daniela Tiaki Uehara; Hidetoshi Abe; Atsushi Ishii; Keiji Moriyama; Shinichi Hirose; Johji Inazawa
Journal:  J Hum Genet       Date:  2019-08-30       Impact factor: 3.172

5.  Genotype-phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)/PIGN-related epilepsy.

Authors:  Leah Fleming; Monica Lemmon; Natalie Beck; Maria Johnson; Weiyi Mu; David Murdock; Joann Bodurtha; Julie Hoover-Fong; Ronald Cohn; Thangamadhan Bosemani; Kristin Barañano; Ada Hamosh
Journal:  Am J Med Genet A       Date:  2015-09-23       Impact factor: 2.802

6.  Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage.

Authors:  Young Jae Woo; Alexandros K Kanellopoulos; Parisa Hemati; Jill Kirschen; Rebecca A Nebel; Tao Wang; Claudia Bagni; Brett S Abrahams
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

7.  A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.

Authors:  Zehra Agha; Zafar Iqbal; Tjitske Kleefstra; Christiane Zweier; Rolph Pfundt; Raheel Qamar; Hans VAN Bokhoven; Marjolein H Willemsen
Journal:  Genet Res (Camb)       Date:  2015-10-06       Impact factor: 1.588

8.  Prader-Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults.

Authors:  A M Manzardo; N Weisensel; S Ayala; W Hossain; M G Butler
Journal:  Clin Genet       Date:  2018-02-05       Impact factor: 4.438

9.  Chromosomal Microarray Analysis in Children with Unexplained Developmental Delay/Intellectual Disability.

Authors:  Pinar Arican; Nihal Olgac Dundar; Berk Ozyilmaz; Dilek Cavusoglu; Pinar Gencpinar; Kadri Murat Erdogan; Merve Saka Guvenc
Journal:  J Pediatr Genet       Date:  2018-12-14

10.  SNP array screening of cryptic genomic imbalances in 450 Japanese subjects with intellectual disability and multiple congenital anomalies previously negative for large rearrangements.

Authors:  Daniela Tiaki Uehara; Shin Hayashi; Nobuhiko Okamoto; Seiji Mizuno; Yasutsugu Chinen; Rika Kosaki; Tomoki Kosho; Kenji Kurosawa; Hiroshi Matsumoto; Hiroshi Mitsubuchi; Hironao Numabe; Shinji Saitoh; Yoshio Makita; Akira Hata; Issei Imoto; Johji Inazawa
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.